Efficacy of Dorzagliatin and Related Factors in a Real-World Cohort of Type 2 Diabetes
Conclusions: Dorzagliatin is effective in lowering glucose levels in patients with T2D in a real-world setting. Patients with lower BMI, higher baseline HbA1c, and shorter duration of disease may be robust responders to dorzagliatin treatment.
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/jdr/9950032 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|